Transgene to attend Investor Access event with institutional investors

• Transgene will meet institutional investors at the Investor Access Event on Oct. 6, 2026, in Paris.
• Management plans to discuss progress on its myvac platform, including TG4050 and TG4070 programs.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Transgene SA published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610011145PRIMZONEFULLFEED1001275811) on October 01, 2026, and is solely responsible for the information contained therein.